Dexcom real-time continuous glucose monitoring (rt-CGM) systems are suitable for anyone with diabetes over the age of 2 years. Whether treated with multiple daily injections or insulin pump therapy, they can benefit real-time CGM.
Updated NICE Guidelines - Great news for access to real time CGM
NICE Guidelines for Adults
NICE now recommends that adults with type 1 diabetes are offered a choice of glucose sensor, including rt-CGM.3
Children & Young People
Real-time continuous glucose monitoring (rt-CGM) should be offered to all children and young people with type 1 diabetes.4
Type 2 diabetes
For people with insulin treated type 2 diabetes, NICE now recommends that rt-CGM can be considered as an alternative to isCGM (Intermittently Scanned Continuous Glucose Monitoring).5
Change the lives of people with diabetes. Choose Dexcom real-time CGM.
The range of Dexcom products allows you to offer access to real-time CGM to all people with diabetes, as recommended in the updated NICE guidelines.3,4,5
Dexcom ONE+ real-time CGM System
Best for people with type 1 or type 2 diabetes using insulin looking for an easy‡‡,9 and accessible CGM system.
Dexcom G6 and Dexcom G7 real-time CGM System
Best for people with type 1 diabetes who may need extra support such as people who are hypo unaware, pregnant or children and those that want connectivity with insulin delivery systems and health or lifestyle apps.
More Insight Than Monitoring Alone
Unlike a single reading from a blood glucose meter, real-time CGM provides dynamic information about the direction of glucose change, giving continuous and timely feedback on nutrition, activity, and insulin requirements to help make informed diabetes treatment decisions. Real-time CGM is a powerful therapy management tool that can inform better diabetes treatment decisions, ultimately leading to tighter glycaemic control, than using a blood glucose meter alone.1,||
Accessing Dexcom for Your Clinic
Updated NICE Guidelines - Great news for access to real time CGM
NICE Guidelines for Adults3
NICE now recommends that adults with type 1 diabetes are offered a choice of glucose sensor, including rt-CGM
Children and Young People4
Real-time continuous glucose monitoring (rt-CGM) should be offered to all children and young people with type 1 diabetes.
Type 2 diabetes5
For people with insulin treated type 2 diabetes, NICE now recommends that rt-CGM can be considered as an alternative to isCGM (intermittent scanning continuous glucose monitoring).
Dexcom is the offers a range of real-time CGM products tailored to the needs of all people with diabetes using insulin.
The Dexcom G6 was proven to be a highly cost-effective management option compared to finger sticking for T1D patients with elevated HbA1c levels. This falls well below the NICE willingness to pay threshold of £20,000 per QALY gained, at £9,558 per QALY gained. Based on the NHS funding criteria, it is estimated that up to 70% of patients with T1D may be eligible for the Dexcom G6.2,||
Please refer to the Diabetes UK. Type 1 Diabetes Technology: A Consensus Guideline for further details on identifying those that could benefit from real-time Continuous Glucose Monitoring (CGM) technology.
§ Compatible insulin-delivery device sold separately.
1 Pettus J et al. Endocr Pract. 2015; 21(6):613-620.
2 Roze S. et al. Diabetes Care. 2020; 43(10):2411-2417.
|| Results obtained with a prior generation Dexcom CGM system; similar results expected with Dexcom G7 given similar or better performance and enhanced feature sets and usability.
3 Type 1 diabetes in adults: diagnosis and management NICE guideline [NG17]
5 Type 2 diabetes in adults: management NICE guideline [NG28]